Title |
Putting an ‘End’ to HIV mRNAs: capping and polyadenylation as potential therapeutic targets
|
---|---|
Published in |
AIDS Research and Therapy, December 2013
|
DOI | 10.1186/1742-6405-10-31 |
Pubmed ID | |
Authors |
Jeffrey Wilusz |
Abstract |
Like most cellular mRNAs, the 5' end of HIV mRNAs is capped and the 3' end matured by the process of polyadenylation. There are, however, several rather unique and interesting aspects of these post-transcriptional processes on HIV transcripts. Capping of the highly structured 5' end of HIV mRNAs is influenced by the viral TAT protein and a population of HIV mRNAs contains a trimethyl-G cap reminiscent of U snRNAs involved in splicing. HIV polyadenylation involves active repression of a promoter-proximal polyadenylation signal, auxiliary upstream regulatory elements and moonlighting polyadenylation factors that have additional impacts on HIV biology outside of the constraints of classical mRNA 3' end formation. This review describes these post-transcriptional novelties of HIV gene expression as well as their implications in viral biology and as possible targets for therapeutic intervention. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 50% |
Unknown | 2 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 75% |
Scientists | 1 | 25% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 57 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 8 | 14% |
Researcher | 8 | 14% |
Student > Bachelor | 6 | 11% |
Student > Master | 5 | 9% |
Student > Postgraduate | 4 | 7% |
Other | 8 | 14% |
Unknown | 18 | 32% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 16 | 28% |
Agricultural and Biological Sciences | 12 | 21% |
Immunology and Microbiology | 4 | 7% |
Social Sciences | 2 | 4% |
Nursing and Health Professions | 1 | 2% |
Other | 4 | 7% |
Unknown | 18 | 32% |